v3.26.1
Acquisition - Contingent Consideration (Details) - Scale BioScience Inc. Acquisition
$ in Thousands
6 Months Ended
Jun. 30, 2026
USD ($)
Business Combination [Line Items]  
Beginning of period $ 24,600
Change in fair value of contingent consideration 3,545
End of period 10,060
Contingent Consideration  
Business Combination [Line Items]  
Settlement of contingent consideration to sellers in cash (8,703)
Settlement of contingent consideration to sellers in equity (8,703)
Assumed Liabilities  
Business Combination [Line Items]  
Settlement of assumed liabilities to third parties $ (679)